These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma. Yu N; Fu S; Xu Z; Liu Y; Hao J; Zhang A; Wang B Int J Cancer; 2016 Jan; 138(2):451-62. PubMed ID: 26239999 [TBL] [Abstract][Full Text] [Related]
15. Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma. Jahan N; Talat H; Alonso A; Saha D; Curry WT Oncoimmunology; 2019; 8(5):e1577108. PubMed ID: 31069135 [TBL] [Abstract][Full Text] [Related]
16. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells. Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085 [TBL] [Abstract][Full Text] [Related]
17. Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice. Ueha S; Yokochi S; Ishiwata Y; Ogiwara H; Chand K; Nakajima T; Hachiga K; Shichino S; Terashima Y; Toda E; Shand FH; Kakimi K; Ito S; Matsushima K Cancer Immunol Res; 2015 Jun; 3(6):631-40. PubMed ID: 25711759 [TBL] [Abstract][Full Text] [Related]
18. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Amoozgar Z; Kloepper J; Ren J; Tay RE; Kazer SW; Kiner E; Krishnan S; Posada JM; Ghosh M; Mamessier E; Wong C; Ferraro GB; Batista A; Wang N; Badeaux M; Roberge S; Xu L; Huang P; Shalek AK; Fukumura D; Kim HJ; Jain RK Nat Commun; 2021 May; 12(1):2582. PubMed ID: 33976133 [TBL] [Abstract][Full Text] [Related]
19. The Role of Anti-Drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice. Brunn ND; Mauze S; Gu D; Wiswell D; Ueda R; Hodges D; Beebe AM; Zhang S; Escandón E J Pharmacol Exp Ther; 2016 Mar; 356(3):574-86. PubMed ID: 26669426 [TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]